You are here

Article info

Article menu
Download PDFPDF
Letter
Lumiracoxib inhibits cyclo-oxygenase 2 completely at the 50 mg dose: is liver toxicity avoidable by adequate dosing?

Authors

  1. Dr B Hinz, Institute of Toxicology and Pharmacology, University of Rostock, Schillingallee 70, D-18057 Rostock, Germany; burkhard.hinz{at}med.uni-rostock.de
View Full Text

Citation

Hinz B, Renner B, Cheremina O, et al
Lumiracoxib inhibits cyclo-oxygenase 2 completely at the 50 mg dose: is liver toxicity avoidable by adequate dosing?
Annals of the Rheumatic Diseases 2009;68:289-291.

Publication history

  • Accepted March 30, 2008
  • First published January 12, 2009.
Online issue publication 
October 31, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group and European League Against Rheumatism